Enzymes of uracil catabolism in normal and neoplastic human tissues.
about
Novel disease-causing mutations in the dihydropyrimidine dehydrogenase gene interpreted by analysis of the three-dimensional protein structureChemotherapy with enteric-coated tegafur/uracil for advanced hepatocellular carcinomaβ-Alanine and orotate as supplements for cardiac protectionCircadian rhythm of dihydrouracil/uracil ratios in biological fluids: a potential biomarker for dihydropyrimidine dehydrogenase levels.Relationships between body composition parameters and fluorouracil pharmacokineticsConstruction of possible integrated predictive index based on EGFR and ANXA3 polymorphisms for chemotherapy response in fluoropyrimidine-treated Japanese gastric cancer patients using a bioinformatic methodLack of effect of interferon alpha 2a upon fluorouracil pharmacokinetics.Mutations at codon 974 of the DPYD gene are a rare event.Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours5-Ethynyluracil (776C85): a potent modulator of the pharmacokinetics and antitumor efficacy of 5-fluorouracil.Unpredicted severe toxicity after 5-fluorouracil treatment due to dihydropyrimidine dehydrogenase deficiency.ELFN1-AS1: a novel primate gene with possible microRNA function expressed predominantly in human tumors.Personalizing colon cancer therapeutics: targeting old and new mechanisms of action.MicroRNA-302b Enhances the Sensitivity of Hepatocellular Carcinoma Cell Lines to 5-FU via Targeting Mcl-1 and DPYD.Pyrimidine base degradation in cultured murine C-1300 neuroblastoma cells and in situ tumors.Silencing of NRF2 Reduces the Expression of ALDH1A1 and ALDH3A1 and Sensitizes to 5-FU in Pancreatic Cancer Cells.Influence of pH on the uptake of 5-fluorouracil into isolated tumour cells.Clinical significance of dihydropyrimidine dehydrogenase in adjuvant 5-fluorouracil liver perfusion chemotherapy for pancreatic cancer.Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil.Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells.Inhibition of catabolic pathway of 5-fluorouracil by 3-cyano-2,6-dihydroxypyridine in human lung cancer tissues.Oral administration of BOF-A2 to rats with lung transplanted tumors results in increased 5-fluorouracil levels.Relationship between protein levels and gene expression of dihydropyrimidine dehydrogenase in human tumor cells during growth in culture and in nude mice.
P2860
Q24296496-3088BD98-658B-4CB7-9821-8F735946ECEFQ24648764-37FBCF1D-4E11-4718-88B2-AFF554D172B6Q34304463-0AFF1EF4-6E09-4C9A-9857-068BBBA16B18Q35046159-38E4EAA7-1B7E-4D5E-85F5-24D1DE9DC44BQ35803944-D1CC55DE-451E-442C-A87F-AF924193FE08Q35811012-27968405-16D9-4527-AE66-920C232071E9Q36079740-B37B2BF6-0AC1-4A0B-9273-2757E4C4D95EQ36116010-9CF4395A-58D3-4BB6-8BF6-2034337D1342Q36295138-96A6D6D2-C75A-4C9B-A09E-8EC52CFCCCAEQ36688040-3A6D754A-D4B7-4A5C-8E2E-4C200CCCF88DQ37475866-B2A5E938-D8D4-446B-8F93-64F32B0700D0Q37636345-F53AD16E-FBCF-4E14-97A1-E22B491E588AQ38166233-E59A319A-97CF-4FD4-AB14-5CDAB5D5CF3FQ38828682-259184A3-EB84-4F41-BCC4-9207E1D4A64AQ40510846-0BCB6236-3A2E-4AD8-AAB7-F451C0A3EBB2Q41662828-9B0E7041-DA5E-4C59-80E0-08B313939441Q42858753-5E69F43A-926E-4F6B-B72F-2CF19332DA46Q45113388-2E7B95F5-29D9-434E-8542-5B9CD6C20897Q50513130-552236CD-638C-4388-AE65-7B5FB00A4356Q54983473-49B5ED1A-542B-47C6-A830-7EF571A8343BQ55244501-6C1E7533-471E-426D-ABA3-01DD44F10ECCQ55296985-3E3466AE-7E3E-4C3F-B8A2-94992444C60FQ55345481-855DBD25-3F46-4B93-B97A-2FC437402122
P2860
Enzymes of uracil catabolism in normal and neoplastic human tissues.
description
1985 nî lūn-bûn
@nan
1985 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1985 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1985年の論文
@ja
1985年論文
@yue
1985年論文
@zh-hant
1985年論文
@zh-hk
1985年論文
@zh-mo
1985年論文
@zh-tw
1985年论文
@wuu
name
Enzymes of uracil catabolism in normal and neoplastic human tissues.
@ast
Enzymes of uracil catabolism in normal and neoplastic human tissues.
@en
Enzymes of uracil catabolism in normal and neoplastic human tissues.
@nl
type
label
Enzymes of uracil catabolism in normal and neoplastic human tissues.
@ast
Enzymes of uracil catabolism in normal and neoplastic human tissues.
@en
Enzymes of uracil catabolism in normal and neoplastic human tissues.
@nl
prefLabel
Enzymes of uracil catabolism in normal and neoplastic human tissues.
@ast
Enzymes of uracil catabolism in normal and neoplastic human tissues.
@en
Enzymes of uracil catabolism in normal and neoplastic human tissues.
@nl
P2093
P1433
P1476
Enzymes of uracil catabolism in normal and neoplastic human tissues.
@en
P2093
P304
P407
P433
P577
1985-11-01T00:00:00Z